HOME >> BIOLOGY >> NEWS
Other Highlights in the June 2 JNCI

Biomarker Could Help Detect Prostate Cancer
A new study shows how testing for an immune response to the prostate cancer biomarker alpha-methylacyl-CoA racemase (AMACR) could be used to help detect prostate cancer in men with intermediate prostate-specific antigen (PSA) levels.

Although PSA screening for prostate cancer has become widespread in the United States, the test has a high rate of false positives because benign diseases, such as prostate enlargement, can increase PSA levels. AMACR expression has been shown to be increased in prostate cancers, but AMACR levels in blood are too low to be detected.

To determine whether an immune response to AMACR could be used instead as a biomarker for prostate cancer, Arul M. Chinnaiyan, M.D., Ph.D., of the University of Michigan Medical School in Ann Arbor, and colleagues used protein microarrays to look for an immune response to AMACR in patients with prostate cancer and in healthy control subjects. The patients with prostate cancer all had a higher immune response to AMACR compared with the control subjects. The authors suggest that the test may be useful in detecting prostate cancer and reducing the number of biopsies done, particularly in men who have intermediate PSA levels.

In an editorial, H. Ballentine Carter, M.D., and William B. Isaacs, Ph.D., of Johns Hopkins School of Medicine in Baltimore, write, "The value of the present study may be the proof of principle that screening for an immune response to cancer-specific antigens by using protein microarrays could lead to improved biomarkers of disease."

Contact: Sally Pobojewski, Senior Science Writer, University of Michigan Medical School, 734-764-2220, pobo@umich.edu

More Effective Method of PLK1 Gene Silencing Inhibits Tumor Growth
The therapeutic use of gene silencing through RNA interference with small interfering RNAs is limited because its effects last for at
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
1-Jun-2004


Page: 1 2 3 4

Related biology news :

1. Other highlights in the September 1 JNCI
2. Other highlights in the August 18 JNCI
3. Other highlights in the August 4 JNCI
4. Other highlights in the July 7 JNCI
5. Other highlights in the June 16 JNCI
6. Other highlights in the May 19 JNCI
7. Other highlights in the May 5 JNCI
8. Other highlights of the March 17 issue of JNCI
9. Other highlights in the March 3 issue of JNCI
10. Other highlights in the February 18 issue of JNCI
11. Other highlights in the February 4 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/29/2020)... ... January 29, 2020 , ... ... new Analytics and Data Sciences practice, providing consulting services for strategy, research and ... announced by Mike Townley, co-founder and Managing Partner of CREO, an innovative management ...
(Date:1/28/2020)... KING OF PRUSSIA, Pa. and CAMBRIDGE, Mass. (PRWEB) , ... ... ... organization dedicated to solving complex problems for life sciences companies and government agencies, ... the largest life sciences hubs in the country. Tunnell’s Cambridge office will be ...
(Date:1/27/2020)... ... 27, 2020 , ... Cytonus Therapeutics Inc. today announced the ... and former senior management consultant at McKinsey & Company who holds three Harvard ... firm. , “Chris Thorne has exceptional business acumen with a proven track ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the leading innovator in ... led by Halma plc , a FTSE 100 global group of life-saving ... and WSJ Joshua Fund. A representative from Halma will join the Valencell board ...
(Date:1/22/2020)... , ... January 20, 2020 , ... ... a partnership with WAVE Electronics, the largest independent electronics distributor in the US, ... purchase Brilliant Smart Home Systems with leading smart home products from a single ...
(Date:1/10/2020)... ... January 09, 2020 , ... Phlexglobal, the leading ... acquisition of Cunesoft, a move that expands the company’s portfolio of best-of-breed technologies ... companies. , Based in Munich, Germany, Cunesoft provides intelligent software and expert services ...
(Date:1/7/2020)... N.J. (PRWEB) , ... January 07, 2020 , ... Vuja ... prevent cancer progression and recurrence, today announced the appointments of Chand Khanna, DVM, PhD, ... Co-founder and CEO of Vuja De said, “We are delighted to welcome Chand and ...
Breaking Biology Technology:
Cached News: